Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Mehta, Anand S.

Medical University Of South Carolina
United States

Glycan Biomarkers for Cholangiocarcinoma 1R01CA289381-01A1 Sidney Fu, M.D.
Melemedjian, Ohannes Kevork

University Of Maryland Baltimore
United States

Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy 4R01CA249939-02 Rachel Altshuler, Ph.D.
Mello-Thoms, Claudia R

University Of Iowa
United States

Satisfaction of Search in Breast Cancer Detection 5R01CA259048-05 Richard Mazurchuk, Ph.D.
Metzger, Gregory John

University Of Minnesota
United States

Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI 5R01CA241159-04 Richard Mazurchuk, Ph.D.
Milanovich, Samuel J

Sanford Research/Usd
United States

Sanford Community Cancer Program of the North Central Plains (NCORP) 5UG1CA189825-11 Vanessa A. White, M.P.H.
Milbury, Kathrin

University Of Tx Md Anderson Can Ctr
United States

Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers 4R37CA231522-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Miyano, Masaru

Beckman Research Institute/City Of Hope
United States

Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials 1R03CA300614-01 Sidney Fu, M.D.
Morilak, David A

University Of Texas Hlth Science Center
United States

Therapy-induced cognitive impairment in a rat model of prostate cancer 5R01CA285183-02 John Clifford, Ph.D.
Moscicki, Anna-Barbara

University Of California Los Angeles
United States

Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies 5R01CA281293-03 Maria Silvina Frech, Ph.D., M.S.
Mosher, Catherine E

Indiana University Indianapolis
United States

Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02